543828 — Sudarshan Pharma Industries Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for Sudarshan Pharma Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,571	4,613	4,635	5,050	7,031
Cost of Revenue
Gross Profit	192	304	411	653	837
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,469	4,473	4,420	4,716	6,555
Operating Profit	102	140	216	334	475
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	71.9	95	152	200	305
Provision for Income Taxes
Net Income After Taxes	53	70.4	115	150	234
Minority Interest
Net Income Before Extraordinary Items
Net Income	53	70.4	115	150	233
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	53	70.4	115	150	233
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.552	0.561	0.476	0.707	0.97
Dividends per Share